Capricor Therapeutics, Inc. Speaks At Panel On Regulation Of Stem Cell-Derived Therapeutic Products At Drug Information Association 2014 50th Annual Meeting
Published: Jun 20, 2014
LOS ANGELES, June 19, 2014 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced that Dr. Rachel Ruckdeschel Smith, Ph.D., Vice President of Research and Development at Capricor, participated in a panel discussion on the regulation of therapeutic products derived from human stem cells at the DIA 2014 50th Annual Meeting, being held June 15-19, 2014 in San Diego, California.
Help employers find you! Check out all the jobs and post your resume.